Boston Scientific Corporation: Varicose Veins trials

The registry lists 10 Varicose Veins studies with Boston Scientific Corporation as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 1Phase 2 3Phase 3 4Phase 4 2No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS)TerminatedNCT05312970Phase 4Results posted
• COMFORT: A Multicenter, Open-label, Randomized, Crossover StudyCompletedNCT02462720Phase 4Results posted
• Pharmacokinetic Study of Polidocanol Endovenous Microfoam (PEM)CompletedNCT01428076Phase 1Results posted
• Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) IncompetenceCompletedNCT01231373Phase 3Results posted
• Endovenous Ablation With and Without Polidocanol Endovenous Microfoam Treatment for Patients With Great Saphenous Vein Incompetence and Visible VaricositiesCompletedNCT01197833Phase 3Results posted
• Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) IncompetenceCompletedNCT01072877Phase 3Results posted
• An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose VeinsCompletedNCT00928421Phase 2Results posted
• Randomized, Single Blind, Placebo Controlled, to Evaluate Efficacy and Safety of Polidocanol Injectable Foam for Treatment of Symptomatic, Visible Varicose Veins With SFJ IncompetenceCompletedNCT00758420Phase 2/3Results posted
• Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac ShuntCompletedNCT00442364Phase 2Results posted
• Validity of Electronic Diary for Monitoring Varicose Veins SymptomsCompletedNCT01200199